SCHEMBL13883155

SCHEMBL13883155

NC(=O)Cc1cc(=O)[nH]c(=O)[nH]1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.57
HSD17B10 Q99714 5/20 0.54
TSHR P16473 3/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
MAPT P10636 1/20 0.50
THRB P10828 1/20 0.48
HTT P42858 1/20 0.48
CASP1 P29466 1/20 0.47
CASP7 P55210 1/20 0.47
GPR84 Q9NQS5 1/20 0.44
USP2 O75604 2/20 0.44
ALDH1A1 P00352 1/20 0.44
LMNA P02545 1/20 0.44
SIRT1 Q96EB6 1/20 0.44
TP53 P04637 4/20 0.43
TYMP P19971 2/20 0.42
UNG P13051 1/20 0.41
RAB9A P51151 1/20 0.39
CYP1A2 P05177 1/20 0.39
CA1 P00915 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2108830 0.82 SMN1; SMN2 (0.59) SMN1; SMN2HSD17B10TSHRL3MBTL1MAPT
SCHEMBL21328426 0.81 TSHR (0.53) SMN1; SMN2HSD17B10TSHRL3MBTL1MAPT
SCHEMBL18130011 0.78 SMN1; SMN2 (0.56) SMN1; SMN2HSD17B10TSHRL3MBTL1MAPT
SCHEMBL18130013 0.78 SMN1; SMN2 (0.56) SMN1; SMN2HSD17B10TSHRL3MBTL1MAPT
SCHEMBL13883659 0.77 SMN1; SMN2 (0.40) SMN1; SMN2HSD17B10TSHRL3MBTL1MAPT
SCHEMBL14123250 0.76 SMN1; SMN2 (0.71) SMN1; SMN2HSD17B10TSHRL3MBTL1MAPT
SCHEMBL6066218 0.74 PDPK1 (0.54) SMN1; SMN2HSD17B10TSHRL3MBTL1MAPT
SCHEMBL2959182 0.74 GPR84 (0.50) SMN1; SMN2HSD17B10TSHRL3MBTL1MAPT
SCHEMBL2961220 0.73 SMN1; SMN2 (1.00) SMN1; SMN2HSD17B10TSHRL3MBTL1MAPT
SCHEMBL22640015 0.72 HSD17B10 (0.75) SMN1; SMN2HSD17B10TSHRL3MBTL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009049018-A1 NOVEL COMPOUNDS AND METHODS OF USING THEM SYNDAX PHARMACEUTICALS, INC. (US) 2009-04-16 WO disclosed